Shantell Laketa Heiber

Array ( [id] => 1271740 [patent_doc_number] => 06653465 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-25 [patent_title] => 'Spliced gene of KSHV / HHV8, its promoter and monoclonal antibodies specific for LANA2' [patent_app_type] => B2 [patent_app_number] => 09/733728 [patent_app_country] => US [patent_app_date] => 2000-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 18631 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653465.pdf [firstpage_image] =>[orig_patent_app_number] => 09733728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1043567 [patent_doc_number] => 06867000 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-15 [patent_title] => 'Method of enhancing immune responses to herpes' [patent_app_type] => utility [patent_app_number] => 10/169057 [patent_app_country] => US [patent_app_date] => 2000-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12843 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/867/06867000.pdf [firstpage_image] =>[orig_patent_app_number] => 10169057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278942 [patent_doc_number] => 06641818 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Cellular proteins which mediate herpesvirus entry' [patent_app_type] => B1 [patent_app_number] => 09/723368 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 100 [patent_no_of_words] => 38762 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/641/06641818.pdf [firstpage_image] =>[orig_patent_app_number] => 09723368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1280329 [patent_doc_number] => 06642008 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Assays and therapies for latent viral infection' [patent_app_type] => B1 [patent_app_number] => 09/718693 [patent_app_country] => US [patent_app_date] => 2000-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13759 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642008.pdf [firstpage_image] =>[orig_patent_app_number] => 09718693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640628 [patent_doc_number] => 06395283 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Equine herpesvirus type 1 glyocoprotein D (EHV-1gD)' [patent_app_type] => B1 [patent_app_number] => 09/717577 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 83 [patent_figures_cnt] => 105 [patent_no_of_words] => 34475 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395283.pdf [firstpage_image] =>[orig_patent_app_number] => 09717577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1260436 [patent_doc_number] => 06663872 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Hemorrhagic enteritis virus DNA sequences, proteins encoded thereby and various uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/717364 [patent_app_country] => US [patent_app_date] => 2000-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 24565 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/663/06663872.pdf [firstpage_image] =>[orig_patent_app_number] => 09717364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1106633 [patent_doc_number] => 06808709 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-26 [patent_title] => 'Immunoglobulins containing protection proteins and their use' [patent_app_type] => B1 [patent_app_number] => 09/717888 [patent_app_country] => US [patent_app_date] => 2000-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 42492 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/808/06808709.pdf [firstpage_image] =>[orig_patent_app_number] => 09717888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1366726 [patent_doc_number] => 06562345 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Immuno-reactive peptide CTL epitopes of human cytomegalovirus' [patent_app_type] => B1 [patent_app_number] => 09/692170 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 36 [patent_no_of_words] => 15693 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562345.pdf [firstpage_image] =>[orig_patent_app_number] => 09692170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1531797 [patent_doc_number] => 06410247 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Nuclear matrix protein fluid assay' [patent_app_type] => B1 [patent_app_number] => 09/687188 [patent_app_country] => US [patent_app_date] => 2000-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 9408 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410247.pdf [firstpage_image] =>[orig_patent_app_number] => 09687188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1577813 [patent_doc_number] => 06448074 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells' [patent_app_type] => B1 [patent_app_number] => 09/685408 [patent_app_country] => US [patent_app_date] => 2000-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2795 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448074.pdf [firstpage_image] =>[orig_patent_app_number] => 09685408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1304512 [patent_doc_number] => 06616929 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-09 [patent_title] => 'Swine vesicular disease virus expression vectors' [patent_app_type] => B1 [patent_app_number] => 09/684546 [patent_app_country] => US [patent_app_date] => 2000-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3245 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/616/06616929.pdf [firstpage_image] =>[orig_patent_app_number] => 09684546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1564990 [patent_doc_number] => 06376172 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Mixed cell diagnostic systems' [patent_app_type] => B1 [patent_app_number] => 09/661849 [patent_app_country] => US [patent_app_date] => 2000-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16548 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376172.pdf [firstpage_image] =>[orig_patent_app_number] => 09661849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1403917 [patent_doc_number] => 06528066 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Variant varicella-zoster viruses and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/661596 [patent_app_country] => US [patent_app_date] => 2000-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 36380 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528066.pdf [firstpage_image] =>[orig_patent_app_number] => 09661596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1392126 [patent_doc_number] => 06531136 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => 'Equine rhinovirus 1 proteins' [patent_app_type] => B1 [patent_app_number] => 09/660541 [patent_app_country] => US [patent_app_date] => 2000-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 22 [patent_no_of_words] => 25306 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531136.pdf [firstpage_image] =>[orig_patent_app_number] => 09660541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 971870 [patent_doc_number] => 06936255 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-30 [patent_title] => 'Vaccine composition comprising herpes simplex virus and human papilloma virus antigens' [patent_app_type] => utility [patent_app_number] => 10/070479 [patent_app_country] => US [patent_app_date] => 2000-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8133 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936255.pdf [firstpage_image] =>[orig_patent_app_number] => 10070479 [rel_patent_id] =>[rel_patent_doc_number] =>)